PRESS RELEASE published on 03/19/2026 at 08:00, 4 months 20 days ago ecotel publishes 2025 Annual Report: Strategic course confirmed – Revenue up 8%, Free Cash Flow significantly increased ecotel communication ag publishes 2025 Annual Report highlighting 8% revenue increase and significant Free Cash Flow growth. Strategic course confirmed for future growth in German telecommunications market Growth Strategy Revenue Increase Ecotel Communication AG 2025 Annual Report Telecommunications Market
PRESS RELEASE published on 03/19/2026 at 08:00, 4 months 20 days ago Transaction in Own Shares Molten Ventures Plc (GROW) announces the purchase of 20,000 own ordinary shares at prices ranging from 464.60p to 474.60p per share Share Repurchase Molten Ventures Plc GROW Share Transaction Deutsche Bank
PRESS RELEASE published on 03/19/2026 at 08:00, 4 months 20 days ago 2025 Full Year Results Announcement Gulf Keystone Petroleum Ltd announces 2025 Full Year Results, achieving strong operational and financial performance, operating in Kurdistan. CEO highlights operational deliveries, increased production, and growth projects. Suspends 2026 guidance due to regional conflicts Financial Results Operational Performance Gulf Keystone Petroleum Ltd Kurdistan 2025 Full Year Results
PRESS RELEASE published on 03/19/2026 at 08:00, 4 months 20 days ago Interim dividend information Gulf Keystone Petroleum Ltd. announces $12.5 million interim dividend of $0.0575 per Common Share in connection with 2025 Full Year Results. Payment date set for 27 April 2026 Dividend Payment Interim Dividend Payment Date Gulf Keystone Petroleum Ltd. 2025 Full Year Results
PRESS RELEASE published on 03/19/2026 at 08:00, 4 months 20 days ago OHB SE: Consolidated financial statements 2025 OHB SE reports significant growth in 2025 with total revenues up by 21%, order intake at EUR 2,078 million, and dividend recommendation of EUR 0.60. Key milestones achieved in space systems segment Financial Statements Order Intake OHB SE Profitable Growth Space Industry
PRESS RELEASE published on 03/19/2026 at 07:50, 4 months 20 days ago AFYREN obtains ISO 9001 certification, a globally acknowledged standard of rigor and performance, for its AFYREN NEOXY plant AFYREN obtains ISO 9001 certification for AFYREN NEOXY plant, showcasing commitment to operational excellence and sustainable solutions Operational Excellence Sustainable Solutions ISO 9001 Certification AFYREN Biobased Ingredients
PRESS RELEASE published on 03/19/2026 at 07:35, 4 months 20 days ago Lenzing advances its transformation: Higher EBITDA, stronger free cash flow and more than EUR 200 million in cost savings Lenzing Group reports higher EBITDA, stronger free cash flow, and over EUR 200 million in cost savings for 2025 despite challenging market conditions Financial Results EBITDA Free Cash Flow Cost Savings Lenzing Group
PRESS RELEASE published on 03/19/2026 at 07:30, 4 months 20 days ago Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1
PRESS RELEASE published on 03/19/2026 at 07:30, 4 months 20 days ago The Nordex Group receives orders totaling 54 MW from Prowind in Germany Nordex Group secures orders totaling 54 MW from Prowind in Germany, highlighting strong collaboration and focus on state-of-the-art technology and sustainable profitability Renewable Energy Germany Nordex Group Wind Turbines Prowind
PRESS RELEASE published on 03/19/2026 at 07:30, 4 months 20 days ago Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation Evotec receives $10 M milestone from Bristol Myers Squibb for Phase 1 clinical study initiation of BMS-986506 in clear cell renal cell carcinoma. Collaboration focuses on protein degradation for cancer treatment Oncology Clinical Study Evotec Bristol Myers Squibb Protein Degradation
Published on 08/07/2026 at 23:15, 21 hours 50 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 22 hours 5 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 22 hours 35 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 22 hours 50 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 4 hours 39 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 21 hours 44 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 1 hour ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 1 hour ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 2 hours ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 1 day 2 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 2 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 1 day 3 hours ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 12 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026